Presentations

      Implementation of an Advanced Workflow to Enhance the Confidence in Compound Identification for Non-Targeted GC-HR-MS Applications

      Dossin, E.; Castellon, A.; Diana, P.; Pospisil, P.; Bentley, M.; Guy, P.

      Conference date
      Jun 3, 2016
      Conference name
      40th International Symposium on Capillary Chromatography (ISCC)
      Link to more information
      Link to more information
      Topic
      Summary

      Chemical characterization still remains a major hurdle for analytical chemists when dealing with non-targeted screening analyses, despite significant improvements in chromatographic separation techniques and mass spectrometric instrumentation over the last decade. This work focuses upon the monitoring of volatile and semi-volatile compounds using gas chromatography coupled to high resolution mass spectrometry (GC-HR-MS) in electron ionization (EI) mode, using both headspace and liquid injection modes. A total of 559 reference compounds, including odd n-alkanes (n=5 to n=19) as chemical markers, were analyzed and experimental linear retention index (LRI) values were determined. A personal compound database library containing EI accurate mass spectra and experimental LRI values was created to enable rapid screening and accurate identification for compounds present in aerosol samples. The reference compounds were used to create computational Quantitative Structure-Property Relationship models using two independent approaches: RapidMiner combined with Dragon software and ACD/ChromGenius software [1, 2]. These models were then used to predict LRI values for several thousand compounds reported to be present in tobacco and tobacco aerosol, plus a range of specific flavor compounds [3]. Using these two prediction models, the mean predicted LRI values for all compounds falling within 500 to 1,900 were calculated and used in conjunction with EI nominal mass spectra (from NIST & Wiley libraries) to enhance the confidence in structural elucidation during complex matrix analysis.  

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.